MARKET

CPRX

CPRX

Catalyst Pharmaceuticals Inc
NASDAQ
31.16
+0.02
+0.06%
Pre Market: 31.15 -0.01 -0.03% 08:56 05/14 EDT
OPEN
31.18
PREV CLOSE
31.14
HIGH
31.19
LOW
31.15
VOLUME
1.44K
TURNOVER
0
52 WEEK HIGH
32.56
52 WEEK LOW
19.05
MARKET CAP
3.81B
P/E (TTM)
17.91
1D
5D
1M
3M
1Y
5Y
1D
Catalyst Pharmaceuticals: Angelini Deal Caps A Potentially Better Story
Seeking Alpha · 21h ago
Catalyst Pharmaceuticals reports Q1 non-GAAP EPS 79c, consensus 64c
TipRanks · 2d ago
Catalyst Pharmaceuticals not providing forward-looking guidance
TipRanks · 2d ago
Catalyst (CPRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
NASDAQ · 2d ago
Catalyst Pharma Reports Higher Revenue, Suspends Earnings Guidance
TipRanks · 2d ago
*Catalyst Pharmaceuticals 1Q Rev $149.4M >CPRX
Dow Jones · 2d ago
Catalyst Pharmaceuticals' Q1 revenue slightly beats estimates on increased prescriber engagement
Reuters · 2d ago
Catalyst Pharmaceuticals, Inc. Non-GAAP EPS of $0.79 beats by $0.15, revenue of $149.3M beats by $1.12M
Seeking Alpha · 2d ago
More
About CPRX
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing medicines for patients living with rare and difficult-to-treat diseases. The Company markets three drug products: FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone). FIRDAPSE is a treatment for people six years of age or older living with Lambert-Eaton myasthenic syndrome (LEMS). The Company, through its sub-licensee, also offers FIRDAPSE in Canada and Japan. FYCOMPA is a prescription medicine used alone or with other medicines to treat partial-onset seizures with or without secondarily generalized seizures in people with epilepsy aged four and older and with other medicines to treat primary generalized tonic-clonic seizures in people with epilepsy aged 12 and older. AGAMREE is a corticosteroid with a structure that retains the potent anti-inflammatory effects of traditional corticosteroids used in Duchenne muscular dystrophy.

Webull offers Catalyst Pharmaceuticals Inc stock information, including NASDAQ: CPRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CPRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CPRX stock methods without spending real money on the virtual paper trading platform.